glp-1 and cancer Agents vs Aspirin: A New Era in Colorectal Prevention JCI - GLP-1 receptor agonists

whether there is a rate-limiting pathway or synergistic/antagonistic crosstalk across cell types and pathological conditions has not been systematically evaluated

That appeared in this chefs kiss of a medical journal: Alternative Therapies in Health and Medicine

Stepwise linear regression analysis found that the variations in initial BUN/Creatinine ratio could be partially predicted by urinary metal excretion at baseline and after the 9 th dose of Phase 1, with an adjusted R 2 = 0.35, p = 0.0001, with the most significant factors being baseline Sn (p = 0.003), baseline W (p = 0.02), and 9 th dose Sb (p = 0.05)

B., Hu, J